Robert Lagacé has over 35 years of experience in the genomics field. From cancer research, to the human genome project, to gene discovery, and lastly targeted assay development. His current role at Thermo Fisher Scientific involves STR assay design for the Rapid platform and leading collaborations efforts with key opinion leaders throughout the world to advance the Rapid platform and massively parallel sequencing solutions for forensics.